In this first-ever proof-of-concept study for the therapeutic potential of human iPSC-derived cells in a pulmonary disease,  Christine Happle and colleagues use Chipcytometry to analyse the successful transplantation of these cells in a humanized mouse model of hereditary pulmonary alveolar proteinosis (herPAP).

https://www.ncbi.nlm.nih.gov/pubmed/29652170

getcomixxx.com
Contact Us

Please tell us how we can help you.

Nicht lesbar? Text ändern. captcha txt

Beginnen Sie mit der Eingabe und drücken Sie Enter, um zu suchen